GrantAdler
City: Bethlehem
Website: www.grantadler.com
Complete development of a new vascular access port and support an expanded sales and distribution effort. GrantAdler is developing and producing a new line of implantable products that allow easier, catheterized access to blood vessels for a variety of procedures. The company’s initial focus is access for administering chemotherapy drugs and for conducting kidney dialysis. Grand Adler’s first product, Rhapsody, which received FDA approval in 2007, has unique design features that make it competitive in the chemotherapy infusion port market.